CSC 2026 Symposium

A New Chapter in Secondary Stroke Prevention: Clinical Insights from Phase III FXIa Inhibitor Trials

Stroke Outcomes Luncheon Symposium at the Canadian Stroke Congress 

May 25, 2026

Available at: https://strokecongress.canadianstroke.ca/recorded-sessions/

Chair:

Dr. Mike Sharma

MD, MSc

Professor of Medicine (Neurology),

McMaster University

Population Health Research Institute

Hamilton, ON

Speakers:

Dr. Ashkan Shoamanesh

MD, FRCPC

Associate Professor of Medicine (Neurology)

McMaster University

Population Health Research Institute

Hamilton, ON

Dr. Laura Gioia

MD, MSc

Stroke Neurologist, CHUM

Clinical Associate Professor of Neurosciences

University of Montreal

Montreal, QC

^{This presentation may contain information regarding investigational products for which market authorization has not been obtained from Health Canada.}

^{MA-M_ASUN-CA-0023-1}